PodcastsScienceBioVenture VoiCes with Chris Garabedian

BioVenture VoiCes with Chris Garabedian

BiotechTV
BioVenture VoiCes with Chris Garabedian
Latest episode

35 episodes

  • BioVenture VoiCes with Chris Garabedian

    Episode 35: INITIATE Ventures' Jessica Owens

    02/23/2026 | 1h 9 mins.
    Jessica Owens discusses the many experiences she has had in her career, including working on the venture side at Kleiner Perkins and Versant Ventures and on the operating side at Genomic Health and Grail. She highlights the value of VCs being able to understand how operators like CEOs think, and describes the type of investing INITIATE focuses on.
  • BioVenture VoiCes with Chris Garabedian

    Episode 34: General Atlantic's Brett Zbar

    02/09/2026 | 1h 7 mins.
    Brett Zbar describes his early career, including working at Aisling Capital and Foresight Capital, and now managing the healthcare strategy at General Atlantic. He describes how he sees the difference between private equity and venture capital, and discusses which themes in biotech and healthcare appeal to him today.
  • BioVenture VoiCes with Chris Garabedian

    Episode 33: Pappas Capital's Art Pappas

    01/26/2026 | 58 mins.
    Art Pappas describes his early career, which involved numerous overseas posts for large companies, and how it let him to eventually found Pappas Capital. He discusses the various ways the firm invests, and how having corporates partners as LPs and co-investors has been a recipe for success.
  • BioVenture VoiCes with Chris Garabedian

    Episode 32: ARCH Venture Partners' Bob Nelsen

    01/11/2026 | 1h 15 mins.
    While describing his early life in Washington and formative years at the University of Chicago that led to the founding of ARCH, he shares his thoughts on leadership, risk taking, changes he thinks are need to keep the United States competitive in life sciences, and his belief in AI's promise to transform our industry.
  • BioVenture VoiCes with Chris Garabedian

    Episode 31: Polaris Partners' Amy Schulman

    12/29/2025 | 1h 2 mins.
    She describes her career beginnings as a lawyer, which led to general counsel and business unit head roles at Pfizer, and then joining the VC world at Polaris Partners (at Bob Langer's urging). She discusses the firm's investment philosophy, the nuances behind how companies choose lead assets, and the cycles biotech has been through over the last ten years. Plus, other roles she currently serves, including being the chair of Alnylam.

More Science podcasts

About BioVenture VoiCes with Chris Garabedian

Hosted by Chris Garabedian, meet the leading Voices in the BioVenture community and hear their insights and perspectives on the challenges and successes with VC investing.
Podcast website

Listen to BioVenture VoiCes with Chris Garabedian, Science Friday and many other podcasts from around the world with the radio.net app

Get the free radio.net app

  • Stations and podcasts to bookmark
  • Stream via Wi-Fi or Bluetooth
  • Supports Carplay & Android Auto
  • Many other app features

BioVenture VoiCes with Chris Garabedian: Podcasts in Family

Social
v8.7.2 | © 2007-2026 radio.de GmbH
Generated: 3/2/2026 - 11:12:51 PM